Home
About
Pricing
Log In

What are you looking for?

Home
Pricing
Back
Compare AU

Compare REIT vs. CURE

Compare shares and ETFs on the ASX that you can trade on Pearler.

VanEck Ftse International Property (Aud Hedged) ETF

ASX

Buy

Buy

Global X S&P Biotech ETF

ASX

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the VanEck Ftse International Property (Aud Hedged) ETF (REIT) and the Global X S&P Biotech ETF (CURE). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

REIT

CURE

Popularity

Low

Low

Pearlers invested

96

82

Median incremental investment

$993.50

$674.92

Median investment frequency

Monthly

Monthly

Median total investment

$1,510.45

$2,274.60

Average age group

> 35

> 35

Key Summary

REIT

CURE

Strategy

REIT.AX was created on 2019-03-29 by VanEck. The fund's investment portfolio concentrates primarily on real estate equity. The ETF currently has 806.57m in AUM and 302 holdings. REIT.AX seeks to provide investors with access to a diversified portfolio of international property securities

CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 46.59m in AUM and 158 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index.

Top 3 holdings

Welltower Inc (10.33 %)

Prologis Inc (7.11 %)

Equinix Inc (6.17 %)

Moderna Inc (2.56 %)

Exelixis Inc (1.79 %)

Amgen Inc (1.79 %)

Top 3 industries

Real Estate (100.00 %)

Other (5.82 %)

Health Care (100.00 %)

Other (10.24 %)

Top 3 countries

United States (75.36 %)

Japan (4.80 %)

United Kingdom of Great Britain and Northern Ireland (3.45 %)

United States (96.74 %)

Switzerland (1.43 %)

United Kingdom of Great Britain and Northern Ireland (1.23 %)

Management fee

0.43 %

0.45 %

Key Summary

REIT

CURE

Issuer

VanEck

Global X

Tracking index

FTSE EPRA NAREIT Developed ex Australia Rental Hedged to AUD Index - AUD

S&P Biotechnology Select Industry

Asset class

ETF

ETF

Management fee

0.43 %

0.45 %

Price

$16.69

$75.82

Size

$844.757 million

$50.157 million

10Y return

N/A

N/A

Annual distribution yield (5Y)

4.35 %

0.03 %

Market

ASX

ASX

First listed date

02/04/2019

12/11/2018

Purchase fee

$6.50

$6.50

Community Stats

REIT

CURE

Popularity

Low

Low

Pearlers invested

96

82

Median incremental investment

$993.50

$674.92

Median investment frequency

Monthly

Monthly

Median total investment

$1,510.45

$2,274.60

Average age group

> 35

> 35

Pros and Cons

REIT

CURE

Pros

  • Lower management fee

  • Higher distribution yield

  • Higher exposure to US market

  • Higher price growth

Cons

  • Lower exposure to US market

  • Lower price growth

  • Higher management fee

  • Lower distribution yield

REIT

CURE

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Higher distribution yield

Lower distribution yield